Machine Learning Discovers Novel Senolytics for Cancer Resea
2026-06-15
The reference study introduces a machine learning approach for discovering senolytic compounds, leading to the identification of three new agents with potent activity against senescent cells. This strategy significantly reduces screening costs and opens new avenues for the rational design of therapies targeting cellular senescence in cancer and age-related diseases.
Long-Term Degarelix Acetate for Chemical Castration in Goats
2026-06-14
This study evaluates the effects of repeated degarelix acetate administration on testicular hormone secretion and morphology in goats, establishing its efficacy as a chemical castration method. The findings reveal rapid and sustained suppression of testosterone and INSL3, accompanied by marked reductions in testicular size and spermatogenesis, supporting degarelix acetate's translational relevance for hormone pathway research.
L-Ornithine: Urea Cycle Intermediate for Metabolic Research
2026-06-13
L-Ornithine, also known as (S)-2,5-diaminopentanoic acid, is a non-proteinogenic amino acid essential for urea cycle function and ammonia detoxification. Its precision in regulating nitrogen disposal and involvement in CNS toxicity research make it a cornerstone biochemical research reagent.
Redefining Translational Oncology: Mechanism-Driven Screenin
2026-06-12
This article provides a strategic, mechanistic perspective for translational researchers on leveraging the DiscoveryProbe™ Anti-cancer Compound Library (L1023) by APExBIO. Integrating recent insights into STING pathway modulation and high-throughput screening, it offers actionable guidance for target validation, precision inhibitor discovery, and future-facing oncology workflows.
LuQi Formula Attenuates Post-MI Remodeling via SPTLC2 Contro
2026-06-12
The cited study elucidates how LuQi Formula (LQF) mitigates ventricular remodeling after myocardial infarction by suppressing SPTLC2-mediated de novo ceramide synthesis. These findings clarify the molecular link between sphingolipid metabolism and cardiac remodeling, offering a new mechanistic rationale for therapeutic intervention targeting serine palmitoyltransferase in heart failure.
CIP2A Drives PKM2 Tetramerization and Oxidative Metabolism i
2026-06-11
The study uncovers how the oncoprotein CIP2A promotes oxidative phosphorylation in non-small cell lung cancer by inducing PKM2 tetramer formation and mitochondrial localization. These findings reshape our understanding of metabolic flexibility in NSCLC and suggest combinatorial targeting of CIP2A and glycolysis as a promising therapeutic strategy.
DiscoveryProbe™ Protease Inhibitor Library: Redefining Preci
2026-06-11
Explore how the DiscoveryProbe Protease Inhibitor Library empowers precision protease inhibition studies and advanced mechanistic research. This article unveils deeper assay design strategies, rigorous library validation, and practical insights not found in existing content.
Estradiol Benzoate: Precision in Estrogen Receptor Alpha Ago
2026-06-10
Estradiol Benzoate stands out as a robust and reproducible tool for dissecting estrogen receptor alpha signaling in both standard and advanced assays. This article delivers real-world workflows, troubleshooting strategies, and cross-referenced optimization tips, making it indispensable for hormone receptor research.
Candida albicans EVs Suppress Hyphal Growth via Nrg1 Upregul
2026-06-10
This study demonstrates that high concentrations of Candida albicans extracellular vesicles (EVs) inhibit hyphal development by upregulating the transcriptional repressor Nrg1, thereby limiting fungal virulence and candidemia in vivo. These findings reveal an intrinsic self-regulatory mechanism in C. albicans with potential implications for antifungal strategies.
SLC25A1 Upregulation Drives Cisplatin Resistance via Senesce
2026-06-09
Li et al. demonstrate that SLC25A1 overexpression confers cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) by promoting cellular senescence through H3K27 acetylation–mediated gene activation. These findings clarify a key mechanism of chemoresistance and suggest SLC25A1 as a predictive biomarker and therapeutic target in HNSCC.
HMGB1 as an Early Serum Biomarker for Diabetic Nephropathy
2026-06-09
This study demonstrates that HMGB1 is significantly elevated in early diabetic nephropathy and could serve as a sensitive serum biomarker for disease monitoring. Using quantitative proteomics and advanced clustering, the research identifies and validates HMGB1’s diagnostic value, addressing a major need for noninvasive early detection.
Alternariol in Mycotoxin Research: Protocols and Practical I
2026-06-08
Alternariol (AOH) is a pivotal tool for dissecting mycotoxin-induced cellular effects, including hepatic fibrosis and apoptosis. This article distills advanced protocol guidance, highlights key innovations from recent omics-driven studies, and delivers troubleshooting strategies for robust, reproducible outcomes in toxin and cytochrome P450 research.
Niclosamide: Applied STAT3 Inhibition for Cancer Research Wo
2026-06-08
Niclosamide stands out as a robust STAT3 pathway inhibitor, enabling precise, reproducible modulation of oncogenic signaling in advanced cancer research models. This guide covers optimized experimental workflows, protocol tips, and troubleshooting strategies, drawing on both foundational and emerging literature to accelerate discovery.
Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele
2026-06-07
This study introduces a zwitterionic peptide amphiphile engineered for sequential activation by matrix metalloproteinase-7 and cathepsin B, enabling highly selective cancer cell targeting via intralysosomal self-assembly. The dual enzyme-responsive approach achieves a high cancer selectivity index and demonstrates significant tumor regression with minimal toxicity, offering a promising direction for peptide-based chemotherapy.
Cyclopamine in Translational Oncology: Mechanisms, Strategie
2026-06-06
This thought-leadership article explores the mechanistic rationale and translational significance of Cyclopamine as a Hedgehog signaling inhibitor, focusing on its evolving role in targeting APOC1-driven pathways in papillary thyroid carcinoma and beyond. Integrating recent data and best practices, it offers strategic guidance for researchers optimizing Cyclopamine in cancer and developmental biology studies.
457 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page